Part AAF-1002B 4D nucleofector core unit, FL1
Ended Awarded
- Contract number
- HHSN26300482
- Awardee
-
Lonza Walkersville, Inc. UEI LEEXJC9L4NF5
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $24,179
Award facts
- Contract value 100% obligated
- $24,179.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
Lonza Walkersville, Inc. was awarded a firm fixed-price BPA call valued at $24,179.40 for a PART AAF-1002B 4D Nucleofector Core Unit, FL1 by the National Institutes of Health Office of the Director. The award, issued on July 23, 2015, with an ultimate completion date of December 31, 2015, was made without a set-aside designation, indicating open competition. The equipment will be delivered to the NIH campus in Bethesda, Maryland. This procurement leverages Lonza Walkersville's existing $10 million single-award Blanket Purchase Agreement with HHS Office of Logistics and Acquisition Operations, which remains valid through December 31, 2025, enabling streamlined acquisition of specialized scientific equipment and biological materials.
The Nucleofector system represents a key piece of research infrastructure supporting NIH's biomedical research mission. Lonza Walkersville, a foreign-owned subsidiary of the global Lonza Group and a registered SAM.gov supplier since 2002, specializes in providing high-precision transfection devices and cell processing equipment to federal research institutions. The company has consistently supported critical research initiatives across multiple NIH institutes, including the National Cancer Institute, National Heart Lung and Blood Institute, and National Institute of Allergy and Infectious Diseases, facilitating studies in cancer, infectious diseases, and regenerative medicine through its specialized scientific instrumentation and biological materials.
Quick answers
Who was awarded contract HHSN26300482?
HHSN26300482 was awarded to Lonza Walkersville, Inc. by Office of the Director (National Institutes of Health) on July 23, 2015.
How much is contract HHSN26300482 worth?
The government has obligated $24,179 on HHSN26300482.
Is contract HHSN26300482 an order under another contract?
Yes. HHSN26300482 is a BPA call under HHSN263199900049886B, a blanket purchase agreement.
Was contract HHSN26300482 competed?
The extent of competition for HHSN26300482 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award